After Nasdaq Uplisting, PharmaCyte Biotech Looks Ready to Rumble Posted byDavid Moadel September 7, 2021 Leave a comment on After Nasdaq Uplisting, PharmaCyte Biotech Looks Ready to Rumble There’s no denying that PharmaCyte Biotech (PMCB) stock has lost much of its value over the years. However, recent developments could catalyze a price…